Senestech (NASDAQ:SNES) Major Shareholder Acquires $13,840.00 in Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management bought 8,000 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was bought at an average cost of $1.73 per share, with a total value of $13,840.00. Following the completion of the acquisition, the insider owned 610,354 shares of the company’s stock, valued at $1,055,912.42. This represents a 1.33% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Friday, February 13th, Glenbrook Capital Management purchased 15,390 shares of Senestech stock. The shares were purchased at an average cost of $1.89 per share, for a total transaction of $29,087.10.
• On Thursday, February 12th, Glenbrook Capital Management purchased 7,956 shares of Senestech stock. The stock was purchased at an average price of $1.72 per share, for a total transaction of $13,684.32.
• On Thursday, February 5th, Glenbrook Capital Management acquired 2,884 shares of Senestech stock. The stock was purchased at an average cost of $1.77 per share, with a total value of $5,104.68.
• On Wednesday, February 4th, Glenbrook Capital Management bought 5,685 shares of Senestech stock. The shares were purchased at an average price of $1.82 per share, for a total transaction of $10,346.70.
• On Monday, February 2nd, Glenbrook Capital Management bought 42,739 shares of Senestech stock. The stock was purchased at an average cost of $1.98 per share, for a total transaction of $84,623.22.
• On Friday, January 30th, Glenbrook Capital Management purchased 5,399 shares of Senestech stock. The stock was purchased at an average price of $1.87 per share, with a total value of $10,096.13.

Senestech Trading Up 12.4%

NASDAQ:SNES opened at $2.00 on Monday. Senestech, Inc. has a 52-week low of $1.30 and a 52-week high of $6.24. The company has a quick ratio of 14.73, a current ratio of 15.75 and a debt-to-equity ratio of 0.01. The stock has a fifty day simple moving average of $2.17 and a 200-day simple moving average of $3.40. The company has a market capitalization of $10.44 million, a PE ratio of -0.55 and a beta of 0.22.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Senestech in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Senestech presently has an average rating of “Hold”.

Institutional Investors Weigh In On Senestech

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Renaissance Technologies LLC boosted its position in Senestech by 35.2% during the fourth quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock worth $306,000 after acquiring an additional 37,165 shares during the last quarter. DRW Securities LLC lifted its stake in shares of Senestech by 171.1% during the 4th quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock worth $176,000 after purchasing an additional 51,818 shares during the period. Sabby Management LLC acquired a new stake in shares of Senestech during the third quarter worth $313,000. Corsair Capital Management L.P. purchased a new stake in shares of Senestech in the second quarter valued at $255,000. Finally, Jane Street Group LLC acquired a new position in Senestech in the second quarter valued at $161,000. 5.19% of the stock is currently owned by hedge funds and other institutional investors.

Senestech Company Profile

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.